Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of heart failure caused by left ventricular systolic dysfunction
- 28 February 1999
- journal article
- review article
- Published by Elsevier BV in Progress in Cardiovascular Diseases
- Vol. 41 (4), 265-300
- https://doi.org/10.1053/pcad.1999.0410265
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Losartan: First of a New Class of Angiotensin Antagonists for the Management of HypertensionThe Journal of Clinical Pharmacology, 1996
- Human Cardiac Fibroblasts Express an Angiotensin Receptor with Unusual Binding Characteristics Which Is Coupled to Cellular ProliferationBiochemical and Biophysical Research Communications, 1994
- Developmental changes in angiotensin II receptor subtypes and AT1 receptor mRNA in rat kidneyKidney International, 1994
- Human Type 2 Angiotensin II Receptor Gene: Cloned, Mapped to the X Chromosome, and Its mRNA Is Expressed in the Human LungBiochemical and Biophysical Research Communications, 1994
- Novel Subtype of Human Angiotensin II Type 1 Receptor: cDNA Cloning and ExpressionBiochemical and Biophysical Research Communications, 1994
- Discrimination of two angiotensin II receptor subtypes with a selective agonist analogue of angiotensin II, p-aminophenylalanine6 angiotensin IIBiochemical and Biophysical Research Communications, 1990
- Preliminary biochemical characterization of two angiotensin II receptor subtypesBiochemical and Biophysical Research Communications, 1989
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984